How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study) (HOPE-HF)
Heart Failure Acute
About this trial
This is an interventional prevention trial for Heart Failure Acute
Eligibility Criteria
Inclusion Criteria:
- Acute Heart Failure Patients Prior to Hospital Discharge
Exclusion Criteria:
- No Cardiac Resynchronization Device Implanted During Current Hospitalization
- Estimated glomerular filtrating rate (GFR) less than 30 ml/min
Sites / Locations
- Hillel Yaffe Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Control Group
Interventional Group
Patients prior to discharge for acute heart failure admission will be examined with a lung impedance device for their suitability for discharge according to their level of pulmonary congestion. Only patients who are unsuitable for discharge according to the lung impedance assessment will be enrolled in the study. The control group (half of the patients) will be discharged without additional intervention.
Patients prior to discharge for acute heart failure admission will be examined with a lung impedance device for their suitability for discharge according to their level of pulmonary congestion. Only patients who are unsuitable for discharge according to the lung impedance assessment will be enrolled in the study. The interventional group (half of the patients) will continue anti-congestive treatment while hospitalized until achieving a suitable level of decongestion.